| Financial Year |
March 31 2023 |
| Monetary Funds |
309,077,344.90 |
| Held-for-trading Financial Assets |
307,785,216.02 |
| Notes Receivable |
6,976,171.99 |
| Accounts Receivable |
290,711,531.03 |
| Advances to Suppliers |
9,326,346.49 |
| Other Receivables |
42,553,575.36 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
91,796,319.71 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
36,662,232.72 |
| Total Current Assets |
1,357,114,293.54 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
65,472,739.65 |
| Investment Properties |
385,856,855.51 |
| Fixed Assetes |
539,084,557.62 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
254,621,775.46 |
| R&D expenses |
234,912,166.23 |
| Goodwill |
485,209,874.23 |
| Long-Term Deferred and Prepaid Expenses |
3,436,024.49 |
| Deferred Income Tax Assets |
44,463,615.11 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
2,452,958,559.22 |
| Total Assets |
3,810,072,852.76 |
| Short-Term Loans |
10,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
189,001,277.31 |
| Accounts Received In Advance |
2,526,953.71 |
| Employee Compensation Payable |
21,164,699.33 |
| Taxes Payable |
83,185,157.02 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
14,705,960.99 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
6,637,574.85 |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
382,628,243.60 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
11,808,679.41 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
39,007,729.47 |
| Total Liabilities |
421,635,973.07 |
| Paid-In Capital(Or Share Stock) |
795,291,951.00 |
| Capital Surplus |
1,160,645,400.22 |
| Surplus Reserve |
141,362,420.42 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,205,910,024.34 |
| Minority Stockholder's Interest |
12,291,017.71 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,376,145,861.98 |
| Owner's Equity（Stockholder's Equity） |
3,388,436,879.69 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,810,072,852.76 |
